Some Seattle doctors are quietly changing the script for women at high genetic risk of ovarian cancer. Instead of going straight to full ovary removal, they are offering a staged option: take out the fallopian tubes now, then wait on the ovaries until later. The goal is to cut off cancers that often start in the tubes, while avoiding the abrupt hormone crash that comes with losing the ovaries too early. For patients juggling fertility, long-term health risks and cancer fears, this "salpingectomy-first" plan is being framed less as an all-or-nothing choice and more as a carefully calibrated compromise.
The strategy works like it sounds: remove the tubes, send them for meticulous analysis, then decide about ovary removal down the road. It is already in use at major research centers and was recently spotlighted in a Seattle-focused profile by KUOW. That story follows Sarah Chen, an OB-GYN and BRCA2 carrier who opted to have her tubes removed first, then returned about five years later for ovary removal. Doctors quoted in the piece, including Johns Hopkins' Dr. Rebecca Stone and UW Medicine chair Dr. Barbara Goff, say this staged plan can buy high-risk patients more time before surgical menopause while still creating a chance to catch early disease that starts in the tubes.
How “Salpingectomy First” Works
Mounting medical evidence points to the far end of the fallopian tube as the starting point for many high-grade serous cancers, the type long lumped under “ovarian” cancer. That shift in thinking has big surgical implications: remove the tubes, and you may intercept cancers that were once assumed to originate on the ovary itself. A systematic review found that bilateral salpingectomy is associated with roughly an 80% reduction in risk for the serous tumors that cause the deadliest ovarian cancers, according to JAMA Surgery. Surgical leaders at Johns Hopkins and elsewhere have pushed for opportunistic removal of the tubes during hysterectomy or sterilization procedures, a trend outlined by Johns Hopkins Medicine.
Surgeons are quick to add that this is risk reduction, not a magic eraser. Tiny bits of tubal tissue can remain attached to the ovary, so salpingectomy does not wipe out the possibility of cancer entirely.
Why Doctors Worry About Early Ovary Removal
Taking out the ovaries before natural menopause is not a small decision. It triggers immediate surgical menopause and is linked with higher long-term risks that include cardiovascular disease, osteoporosis and fractures, Parkinson’s disease and dementia, as well as increased all-cause mortality, concerns that UW Medicine clinicians have emphasized. Hormone replacement therapy can soften many of the short- and medium-term side effects, but it is not an option for everyone, especially people with hormone-sensitive breast cancer.
Clinical reviews and guideline summaries underscore those tradeoffs and explain why a staged approach is under study as a way to preserve ovarian function as long as possible while still cutting cancer risk, according to clinical literature.
Who Might Opt In
For people with pathogenic BRCA variants, current guidance still leans toward earlier ovary removal. Typical recommendations call for surgery around ages 35 to 40 for BRCA1 carriers, and around 40 to 45 for BRCA2. A tubes-first pathway is being evaluated as an alternative for some patients who want to delay surgical menopause, according to professional guidance in Obstetrics & Gynecology.
The TUBA study and related trials published in BMC Cancer have looked at whether salpingectomy with delayed oophorectomy can maintain quality of life and leave more fertility options on the table without undermining cancer prevention. For women at average risk, the lifetime chance of ovarian cancer sits around 1% to 2%. Surgeons say that swapping traditional tubal ligation for salpingectomy during sterilization or hysterectomy could prevent nearly 2,000 ovarian cancer cases in the United States each year, as reported by KUOW.
The Policy Push And What Comes Next
Advocacy and research groups, including the Outsmart Ovarian Cancer collaborative and Break Through Cancer, are campaigning to boost awareness, provider training and insurance coverage for opportunistic salpingectomy, while warning that implementation and equity will determine how effective these efforts really are. Surgical societies and policy briefs have urged surgeons to offer fallopian tube removal during eligible abdominal surgeries and have called for reimbursement changes so the practice is trackable and accessible, recommendations that have been summarized by surgical and advocacy organizations.
In Seattle, clinicians at UW Medicine and other centers say they are updating counseling materials and shared-decision tools so patients can more clearly weigh cancer prevention against fertility plans and long-term health effects.
For anyone with a pathogenic BRCA variant or a striking family history of ovarian or related cancers, experts recommend starting with genetic counseling and then having a detailed conversation with a gynecologic oncologist about timing, fertility preservation strategies and hormone options. Ovarian cancer is still notoriously hard to catch early, and most diagnoses happen at later stages. That reality is a big reason prevention tactics like opportunistic salpingectomy are drawing more attention, according to national cancer statistics and major cancer centers.
